| 发明名称 |
NICOTINAMIDE DERIVATE IN THE TREATMENT OF ACUTE CORONARY SYNDROME |
| 摘要 |
The use of a nicotinamide derivative in the treatment acute coronary syndrome (ACS) and pharmaceutical compositions used in such treatment. |
| 申请公布号 |
US2016367542(A1) |
申请公布日期 |
2016.12.22 |
| 申请号 |
US201615255356 |
申请日期 |
2016.09.02 |
| 申请人 |
GlaxoSmithKline LLC |
发明人 |
Ghirardi Michele;Greenhalgh David;Sprecher Dennis L.;Willette Robert Nicholas |
| 分类号 |
A61K31/455;A61K45/06;A61K47/48;A61K9/00 |
主分类号 |
A61K31/455 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of preventing or reducing the risk or severity of a major adverse cardiac event (MACE) in a subject that has previously experienced an acute coronary syndrome (ACS) event comprising administering the compound 6-(5-cyclopropylcarbamoyl-3-fluoro-2-methyl-phenyl)-N-(2,2-dimethylpropyl)-nicotinamide or a pharmaceutically acceptable salt thereof. |
| 地址 |
Wilmington DE US |
